Many kinds of tumors exhibit overexpression of anti-apoptotic proteins (Mcl-1, Bcl-xL, and Bcl-2), near all anti-tumor drugs targeting the Bcl-2 family have focused on the inhibition of Bcl-xL and Bcl-2 [15]. Here, BCL2 is linked to neoplasm.